TXNDC5 and nonpapillary renal cell carcinoma: also found that the expression of TXNDC5 was negatively correlated with the chemosensitivity of ccRCC, and inhibit the expression of TXNDC5 increased the resistance of ccRCC to chemotherapeutic drugs, reduced the killing of cancer cells by chemotherapeutic drugs, and promoted the development of cancer (143).